Veeva Systems R&D and Quality Solutions — Total revenues remained flat by 0.0% to $80.45M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 72.7%, from $294.94M to $80.45M. Over 2 years (FY 2024 to FY 2026), R&D and Quality Solutions — Total revenues shows a downward trend with a -40.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates successful adoption of the company's core R&D and quality software platforms and expansion within the life sciences customer base, while a decrease may signal market saturation or competitive pressure.
This metric represents the total revenue generated from subscription services and cloud-based software solutions specifi...
Comparable to vertical-specific SaaS revenue metrics for enterprise software providers serving highly regulated industries like healthcare or life sciences.
veev_segment_r_d_and_quality_solutions_total_revenues| FY'24 | FY'25 | FY'26 | |
|---|---|---|---|
| Value | $905.79M | $1.18B | $321.81M |
| YoY Change | — | +30.2% | -72.7% |